Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 28, 2017

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes, Established Cardiovascular Disease, and Chronic Kidney Disease

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease
Circulation 2017 Sep 13;[EPub Ahead of Print], C Wanner, JM Lachin, SE Inzucchi, D Fitchett, M Mattheus, JT George, HJ Woerle, UC Broedl, M von Eynatten, B Zinman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading